Both in Pharmaceuticals
Immuneering vs Lifecore Biomedical
Over the past year IMRX returned −43.9% and LFCR returned −9.7%; their daily moves had a correlation of 0.05.
IMRX −43.9% LFCR −9.7%Growth of $1, one year, split-adjusted
| Metric | IMRX | LFCR |
|---|---|---|
| Price | $3.68 | $6.42 |
| Market cap | $238.3M | $243.4M |
| Today | +5.44% | +0.47% |
| 1 month | −8.9% | −1.5% |
| 6 months | −31.1% | +24.4% |
| Year to date | −44.1% | −21.5% |
| 1 year | −46.4% | −10.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 35.3% |
| Net margin | — | −20.9% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $145.4M | -$136.9M |
| Dividend yield | — | — |
| Volatility (60d) | 53.8% | 96.9% |
| Short % of float | 29.2% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).